BACKGROUND: Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning. Recently other cognitive deficits have been reported. This has led to a modification of MCI criteria. OBJECTIVE: To examine which neuropsychological tests most clearly distinguish MCI subjects from normal controls. METHODS: 112 consecutive MCI subjects and 35 controls were included in the study. The diagnosis of MCI was based on an objective history of cognitive decline and a neuropsychiatric examination, comprising instruments STEP, I-Flex, MMSE, and CDR. Participants were examined with 21 neuropsychological tests in the cognitive domains speed/attention, memory and learning, visuospatial function, language, and executive function. RESULTS: Controls were significantly older. No differences were found in education or general intellectual capacity. Controls performed significantly better than MCI on tests within all five cognitive domains. The clearest differences were seen on language tests, followed by executive function, and learning and memory. Only two subjects (1.8%) were purely amnestic; 17% showed no impairment compared with controls, with a cut off of 1.5 SD below age mean. These subjects were better educated and performed significantly better on measures of general cognitive capacity. CONCLUSIONS: The results illustrate the heterogeneity of MCI, with a significant degree of impairment in all five cognitive domains. When examined with a comprehensive neuropsychological battery, very few subjects had an isolated memory impairment.
BACKGROUND: Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning. Recently other cognitive deficits have been reported. This has led to a modification of MCI criteria. OBJECTIVE: To examine which neuropsychological tests most clearly distinguish MCI subjects from normal controls. METHODS: 112 consecutive MCI subjects and 35 controls were included in the study. The diagnosis of MCI was based on an objective history of cognitive decline and a neuropsychiatric examination, comprising instruments STEP, I-Flex, MMSE, and CDR. Participants were examined with 21 neuropsychological tests in the cognitive domains speed/attention, memory and learning, visuospatial function, language, and executive function. RESULTS: Controls were significantly older. No differences were found in education or general intellectual capacity. Controls performed significantly better than MCI on tests within all five cognitive domains. The clearest differences were seen on language tests, followed by executive function, and learning and memory. Only two subjects (1.8%) were purely amnestic; 17% showed no impairment compared with controls, with a cut off of 1.5 SD below age mean. These subjects were better educated and performed significantly better on measures of general cognitive capacity. CONCLUSIONS: The results illustrate the heterogeneity of MCI, with a significant degree of impairment in all five cognitive domains. When examined with a comprehensive neuropsychological battery, very few subjects had an isolated memory impairment.
Authors: A Wallin; A Edman; K Blennow; C G Gottfries; I Karlsson; B Regland; M Sjögren Journal: J Geriatr Psychiatry Neurol Date: 1996-10 Impact factor: 2.680
Authors: H Wolf; M Grunwald; G M Ecke; D Zedlick; S Bettin; C Dannenberg; J Dietrich; K Eschrich; T Arendt; H J Gertz Journal: J Neural Transm Suppl Date: 1998
Authors: Dorene M Rentz; Terri J Huh; Robert R Faust; Andrew E Budson; Leonard F M Scinto; Reisa A Sperling; Kirk R Daffner Journal: Neuropsychology Date: 2004-01 Impact factor: 3.295
Authors: K Blennow; G De Meyer; O Hansson; L Minthon; A Wallin; H Zetterberg; P Lewczuk; H Vanderstichele; E Vanmechelen; J Kornhuber; J Wiltfang; I Heuser; W Maier; C Luckhaus; E Rüther; M Hüll; H Jahn; H J Gertz; L Frölich; H Hampel; R Pernetzki Journal: J Nutr Health Aging Date: 2009-03 Impact factor: 4.075
Authors: Ana Espinosa; Montserrat Alegret; Mercè Boada; Georgina Vinyes; Sergi Valero; Pablo Martínez-Lage; Jordi Peña-Casanova; James T Becker; Barbara A Wilson; Lluís Tárraga Journal: J Int Neuropsychol Soc Date: 2009-07-02 Impact factor: 2.892
Authors: Elizabeth Guerrero-Berroa; Alan Kluger; James Schmeidler; Kevin Sailor; Humberto Lizardi; James Golomb; Steven Ferris; Barry Reisberg Journal: J Geriatr Psychiatry Neurol Date: 2014-04-22 Impact factor: 2.680
Authors: Maureen Handoko; Marianne Grant; Michael Kuskowski; Kathleen R Zahs; Anders Wallin; Kaj Blennow; Karen H Ashe Journal: JAMA Neurol Date: 2013-05 Impact factor: 18.302